CEL-SCI CORPORATION Increase (Decrease) in Deferred Revenue
CEL-SCI CORPORATION (CVM) reported Increase (Decrease) in Deferred Revenue of $1.55 thousand for the 3-month period ending 2017-12-31, per its 10-Q filed 2018-02-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-02-12
- CEL-SCI CORPORATION increase (decrease) in deferred revenue for the quarter ending 2017-12-31 was $1.55K.
- CEL-SCI CORPORATION increase (decrease) in deferred revenue for the quarter ending 2017-09-30 was $0.00.
- CEL-SCI CORPORATION increase (decrease) in deferred revenue for the quarter ending 2017-06-30 was $0.00.
- CEL-SCI CORPORATION increase (decrease) in deferred revenue for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
- CEL-SCI CORPORATION increase (decrease) in deferred revenue for fiscal 2017 was $0.00.
- CEL-SCI CORPORATION increase (decrease) in deferred revenue for fiscal 2016 was -$1.64K, a 3514.58% decline from fiscal 2015.
- CEL-SCI CORPORATION increase (decrease) in deferred revenue for fiscal 2015 was $48.00, a 4.35% increase from fiscal 2014.
- CEL-SCI CORPORATION increase (decrease) in deferred revenue for fiscal 2014 was $46.00, a 2.22% increase from fiscal 2013.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2017-12-31 | $1.55K 10-Q · filed 2018-02-12 | $1.55K derived: sum of 2 quarters · filed 2018-02-12 | $1.55K derived: sum of 3 quarters · filed 2018-02-12 | $1.55K derived: sum of 4 quarters · filed 2018-02-12 |
| 2017-09-30 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2017-12-29 | $0.00 derived: sum of 2 quarters · filed 2017-12-29 | $0.00 derived: sum of 3 quarters · filed 2017-12-29 | $0.00 10-K · filed 2017-12-29 |
| 2017-06-30 | $0.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-12-11 | $0.00 derived: sum of 2 quarters · filed 2017-12-11 | $0.00 10-Q/A · filed 2017-12-11 | -$1.50K derived: sum of 4 quarters · filed 2018-02-12 |
| 2017-03-31 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2017-12-11 | $0.00 10-Q/A · filed 2017-12-11 | -$1.50K derived: sum of 3 quarters · filed 2018-02-12 | -$1.50K derived: sum of 4 quarters · filed 2018-02-12 |
| 2016-12-31 | $0.00 10-Q · filed 2018-02-12 | -$1.50K derived: sum of 2 quarters · filed 2018-02-12 | -$1.50K derived: sum of 3 quarters · filed 2018-02-12 | $0.00 derived: sum of 4 quarters · filed 2018-02-12 |
| 2016-09-30 | -$1.50K derived: 10-K 12 month − 10-Q/A 9 month · filed 2017-12-29 | -$1.50K derived: sum of 2 quarters · filed 2017-12-29 | $0.00 derived: sum of 3 quarters · filed 2017-12-29 | -$1.64K 10-K · filed 2017-12-29 |
| 2016-06-30 | $0.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-12-11 | $1.50K derived: sum of 2 quarters · filed 2017-12-11 | -$138.00 10-Q/A · filed 2017-12-11 | $1.50K derived: sum of 4 quarters · filed 2017-12-11 |
| 2016-03-31 | $1.50K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-12-11 | -$138.00 10-Q/A · filed 2017-12-11 | $1.50K derived: sum of 3 quarters · filed 2017-12-11 | -$138.00 derived: sum of 4 quarters · filed 2017-12-11 |
| 2015-12-31 | -$1.64K 10-Q/A · filed 2017-12-11 | $0.00 derived: sum of 2 quarters · filed 2017-12-11 | -$1.64K derived: sum of 3 quarters · filed 2017-12-11 | -$1.59K derived: sum of 4 quarters · filed 2017-12-11 |
| 2015-09-30 | $1.64K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-12-11 | $0.00 derived: sum of 2 quarters · filed 2017-12-11 | $48.00 derived: sum of 3 quarters · filed 2017-12-11 | $48.00 10-K/A · filed 2017-12-11 |
| 2015-06-30 | -$1.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09 | -$1.59K derived: sum of 2 quarters · filed 2016-08-09 | -$1.59K 10-Q · filed 2016-08-09 | -$1.59K derived: sum of 4 quarters · filed 2017-12-11 |
| 2015-03-31 | $48.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-10 | $48.00 10-Q · filed 2016-05-10 | $48.00 derived: sum of 3 quarters · filed 2017-12-11 | $48.00 derived: sum of 4 quarters · filed 2017-12-11 |
| 2014-12-31 | $0.00 10-Q · filed 2016-02-09 | $0.00 derived: sum of 2 quarters · filed 2017-12-11 | $0.00 derived: sum of 3 quarters · filed 2017-12-11 | |
| 2014-09-30 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-12-11 | $0.00 derived: sum of 2 quarters · filed 2017-12-11 | $46.00 10-K/A · filed 2017-12-11 | |
| 2014-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-07 | $46.00 10-Q · filed 2015-08-07 | ||
| 2014-03-31 | $46.00 10-Q · filed 2015-05-08 | |||
| 2013-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-11 | $0.00 derived: sum of 2 quarters · filed 2015-12-11 | $45.00 10-K · filed 2015-12-11 | |
| 2013-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-08 | $45.00 10-Q · filed 2014-08-08 | ||
| 2013-03-31 | $45.00 10-Q · filed 2014-05-12 | |||
| 2012-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-23 | $0.00 derived: sum of 2 quarters · filed 2014-12-23 | $1.50K 10-K · filed 2014-12-23 | |
| 2012-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-09 | $1.50K 10-Q · filed 2013-08-09 | ||
| 2012-03-31 | $1.50K 10-Q · filed 2013-05-10 | |||
| 2011-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-27 | $0.00 derived: sum of 2 quarters · filed 2013-12-27 | $0.00 10-K · filed 2013-12-27 | |
| 2011-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-09 | $0.00 10-Q · filed 2012-08-09 | ||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-10 | |||
| 2010-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-14 | $125.00K 10-K · filed 2012-12-14 | ||
| 2010-06-30 | $125.00K 10-Q · filed 2011-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |